Autopsy report · NCT06419166

An Exploratory Clinical Study of GC012F Injection for Refractory gMG

“The study stopped early, before enrolling its first participant.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Zhejiang University

Sponsor type

University, hospital or other

Conditions

Refractory Generalized Myasthenia Gravis

Interventions

GC012F injection

Participants

0

Sites

1

Countries

China

Trials that died the same way

• ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL)
  “Study halted prematurely, prior to enrollment of first participant” (84% match in meaning)
• Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
  “This study was stopped prematurely due to lack of enrollment within a 1-5-year period.” (81% match in meaning)
• Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
  “Study was stopped after interim analysis and slow enrollment.” (79% match in meaning)
• Impact of Keeping a Personal Recovery Diary on Upper Extremity Disability
  “The Principal Investigator left the institution so the study was stopped before completing enrollment.” (78% match in meaning)
• Tiotropium Handihaler vs. Tiotropium Respimat in COPD
  “Study halted prematurely due to funding, prior to enrollment of first participant” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.